Cargando…
Acarbose, lente carbohydrate, and prebiotics promote metabolic health and longevity by stimulating intestinal production of GLP-1
The α-glucosidase inhibitor acarbose, which slows carbohydrate digestion and blunts postprandial rises in plasma glucose, has long been used to treat patients with type 2 diabetes or glucose intolerance. Like metformin, acarbose tends to aid weight control, postpone onset of diabetes and decrease ri...
Autores principales: | McCarty, Mark F, DiNicolantonio, James J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316590/ https://www.ncbi.nlm.nih.gov/pubmed/25685364 http://dx.doi.org/10.1136/openhrt-2014-000205 |
Ejemplares similares
-
Acarbose: safe and effective for lowering postprandial hyperglycaemia and improving cardiovascular outcomes
por: DiNicolantonio, James J, et al.
Publicado: (2015) -
Ferulic acid and berberine, via Sirt1 and AMPK, may act as cell cleansing promoters of healthy longevity
por: DiNicolantonio, James J, et al.
Publicado: (2022) -
Capsaicin may have important potential for promoting vascular and metabolic health
por: McCarty, Mark F, et al.
Publicado: (2015) -
Autophagy-induced degradation of Notch1, achieved through intermittent fasting, may promote beta cell neogenesis: implications for reversal of type 2 diabetes
por: DiNicolantonio, James J, et al.
Publicado: (2019) -
Maintaining Effective Beta Cell Function in the Face of Metabolic Syndrome-Associated Glucolipotoxicity—Nutraceutical Options
por: McCarty, Mark F., et al.
Publicado: (2021)